Idiopathic Pulmonary Fibrosis News and Research

RSS
Pulmonary fibrosi is a condition in which tissue deep in your lungs becomes thick and stiff, or scarred, over time. The development of the scarred tissue is called fibrosis. As the lung tissue becomes thicker, your lungs lose their ability to move oxygen into your bloodstream. As a result, your brain and other organs don't get the oxygen they need.

In some cases, doctors can find out what's causing the fibrosis. But in most cases, they can't find a cause. They call these cases idiopathic pulmonary fibrosis (IPF). IPF is a serious condition. About 200,000 Americans have it. About 50,000 new cases are diagnosed each year. IPF mostly affects people who are 50 to 75 years of age. IPF varies from person to person. In some people, the lung tissue quickly becomes thick and stiff. In others, the process is much slower. In some people, the condition stays the same for years. IPF has no cure yet. Many people live only about 3 to 5 years after diagnosis. The most common cause of death related to IPF is respiratory failure.
Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis

Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis

Study highlights the epigenetics of life at high altitudes

Study highlights the epigenetics of life at high altitudes

Bernese researchers develop a second generation lung-on-chip

Bernese researchers develop a second generation lung-on-chip

ACE2 agonist C21 relieves respiratory difficulty in COVID-19

ACE2 agonist C21 relieves respiratory difficulty in COVID-19

Owlstone Medical introduces breath biopsy panel for respiratory diseases

Owlstone Medical introduces breath biopsy panel for respiratory diseases

BU researchers awarded $2.4 million NIH grant to study idiopathic pulmonary fibrosis

BU researchers awarded $2.4 million NIH grant to study idiopathic pulmonary fibrosis

New collaborative study to address key questions about COVID-19

New collaborative study to address key questions about COVID-19

Research sheds light on the mystery cause of idiopathic pulmonary fibrosis

Research sheds light on the mystery cause of idiopathic pulmonary fibrosis

Researchers develop multi-channel recording device for lung sound analysis

Researchers develop multi-channel recording device for lung sound analysis

Researchers develop telomerase gene therapy for treating different pathologies

Researchers develop telomerase gene therapy for treating different pathologies

New therapy for flu may prove effective against many other pathogenic virus infections

New therapy for flu may prove effective against many other pathogenic virus infections

New therapy developed for flu infections may also prove effective against HIV, COVID-19

New therapy developed for flu infections may also prove effective against HIV, COVID-19

Scientists are developing new treatment option for lung fibrosis

Scientists are developing new treatment option for lung fibrosis

Researchers identify a genetic basis for ANCA-associated vasculitis

Researchers identify a genetic basis for ANCA-associated vasculitis

Researchers identify genetic basis for anti-neutrophil cytoplasmic antibody-associated vasculitis

Researchers identify genetic basis for anti-neutrophil cytoplasmic antibody-associated vasculitis

Researchers assess molecular basis of SARS-CoV-2 severity and poor outcomes in lung disease

Researchers assess molecular basis of SARS-CoV-2 severity and poor outcomes in lung disease

Blood purification outside the body in COVID-19 patients

Blood purification outside the body in COVID-19 patients

TL1A and its receptor could reduce fibrosis and tissue remodeling in patients with severe lung disease

TL1A and its receptor could reduce fibrosis and tissue remodeling in patients with severe lung disease

Study may help develop treatment for age-related pulmonary fibrosis

Study may help develop treatment for age-related pulmonary fibrosis

Powerful treatment for IPF stops dangerous scar formation in mouse lungs

Powerful treatment for IPF stops dangerous scar formation in mouse lungs